ARNIP SNCA AND ITS USES

DOP2026000065AUndetermined Publication Date: 2026-06-30JANSSEN PHARMA NV
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
DO · DO
Patent Type
Applications
Current Assignee / Owner
JANSSEN PHARMA NV
Filing Date
2026-03-06
Publication Date
2026-06-30
Patent Text Reader

Abstract

The present provides small interfering ribonucleic acid (siRNA) agents that target an SNCA gene and compositions comprising such siRNA agents.
Need to check novelty before this filing date? Find Prior Art